[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100450600":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":35,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Saglik Bilimleri Universitesi","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Questionnaire","Cases diagnosed with Idiopathic pulmonary fibrosis (IPF) in the chest diseases outpatient clinic will be informed about the study, and the informed consent form will be signed by the specialist physician and demographic information will be obtained from the cases who accepted to be included in the study.\n\nThe surveys will be contacted by the patient at 1-week intervals and answered by the patient by the responsible researcher and chest diseases physician.",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"ESRA PEHLİVAN, Assoc.Prof.","CONTACT","02164189616","fztesrakambur@yahoo.com",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":7,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Esra Pehlivan","RECRUITING","Istanbul","Üsküdar","34668","Turkey (Türkiye)",{"type":27,"coordinates":28},"Point",[29,30],28.94966,41.01384,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":16,"phoneExt":7,"email":17},"ESRA PEHLİVAN",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","ESRA PEHLIVAN","Principal investigator","100450600","turkish-validity-and-reliability-of-sgrq-i-100450600",false,"NCT05147597","Turkish Validity and Reliability of SGRQ-I","Turkish Validity and Reliability of the Saint George Respiratory Questionnaire Idiopathic Pulmonary Fibrosis Version (SGRQ-I)","Inclusion Criteria:\n\n* Be over 18 years old\n* Having a Diagnosis of Idiopathic Pulmonary Fibrosis\n* To be literate in Turkish\n\nExclusion Criteria:\n\n* Exacerbation or exacerbation in the last 6 weeks\n* Presence of comorbidities affecting ambulation\n* Cognitive impairment","ALL","18 Years",{"count":49,"type":50},180,"ESTIMATED","OBSERVATIONAL","The Saint George Respiratory Questionnaire (SGRQ) questionnaire is a frequently used questionnaire in the respiratory patient group, and the Turkish version of this questionnaire, which was created for use in idiopathic pulmonary fibrosis patients, is not available. There is no commonly used quality of life questionnaire in patients with idiopathic pulmonary fibrosis. The aim of the study is to translate and validate the SGRQ idiopathic pulmonary fibrosis version of questionnaire into Turkish.",[54],"IPF",[56,57,54,58],"SGRQ","SGRQ-I","Quality of life","2025-04-29",{"date":61,"type":62},"2025-05-01","ACTUAL",{"date":64,"type":62},"2022-01-09",{"date":66,"type":50},"2026-01-01",{"name":5,"class":6},1]